US Broker Ratings

Alphatec Holdings (ATEC) Stock Analysis: Navigating a 48.93% Potential Upside Amid Robust Revenue Growth

Alphatec Holdings, Inc. (NASDAQ: ATEC), a burgeoning player in the healthcare sector, is capturing the attention of investors, not just for its innovative spinal disorder treatments,..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Exploring a 21.59% Potential Upside in the CNS Treatment Market

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical company headquartered in Rockville, Maryland, is strategically positioned in the healthcare sector, specifically within the realm of specialty and..

Select Medical Holdings Corp (SEM): Investor Outlook Reveals 35.40% Upside Potential

Select Medical Holdings Corporation (NYSE: SEM) stands as a notable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 51% Upside Potential with Strong Buy Ratings

Veracyte, Inc. (NASDAQ: VCYT), a prominent player in the healthcare sector, specifically in the diagnostics and research industry, is capturing investor attention with its promising growth..

NovoCure Limited (NVCR): Investor Outlook Reveals 91% Potential Upside Amid Healthcare Innovations

NovoCure Limited (NASDAQ: NVCR), a Swiss-based company at the forefront of oncology innovation, presents an intriguing investment opportunity within the healthcare sector, notably in the medical..

Certara, Inc. (CERT) Stock Report: Exploring a 43% Potential Upside Amid Innovative Biosimulation Solutions

Certara, Inc. (NASDAQ: CERT), a prominent player in the healthcare sector, is capturing investor attention with its innovative software products and technology-enabled services. Specializing in biosimulation..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: Unpacking a 51.66% Potential Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is making waves in the healthcare sector, specifically within the niche of drug manufacturing focused on specialty and generic therapeutics. With..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring a Potential 130% Upside in Biotechnology

Denali Therapeutics Inc. (NASDAQ: DNLI), a notable player in the biotechnology sector, is capturing investor attention with its promising pipeline of therapeutics targeting neurodegenerative and lysosomal..

Alvotech (ALVO) Stock Analysis: A Biotech Pioneer with a 60.5% Upside Potential

Alvotech (ALVO), a Luxembourg-based biotech company specializing in biosimilar medicines, is capturing attention in the healthcare investment arena. With a market capitalization of $3.38 billion, Alvotech..

Arrowhead Pharmaceuticals, Inc. (ARWR): Biotechnology Stock with a Potential 171% Upside

Investors eyeing opportunities in the biotechnology sector may want to pay close attention to Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR). With a compelling potential upside of 171.34%,..

LifeStance Health Group, Inc. (LFST) Stock Analysis: A 50% Potential Upside in the Thriving Mental Health Sector

LifeStance Health Group, Inc. (LFST), a burgeoning player in the healthcare sector, is capturing investor attention with its promising potential upside of 50.63%. As a key..

CG Oncology, Inc. (CGON) Stock Analysis: A Potential 125% Upside in Biotech Sector

Investors with a keen eye on the biotechnology sector may find CG Oncology, Inc. (NASDAQ: CGON) an intriguing prospect. With its market capitalization at $2.03 billion..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Biotech Innovator with 69.69% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK), a prominent player in the biotechnology sector, is making waves among investors with its promising drug pipeline and substantial potential..

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook on This Promising Biotechnology Stock with 49% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is making waves in the biopharmaceutical sector, particularly among investors looking for promising opportunities in the biotechnology industry. With a market..

Ardent Health Partners, Inc. (ARDT) Stock Analysis: Unlocking a Potential 41% Upside

Ardent Health Partners, Inc. (ARDT), a key player in the U.S. healthcare sector, is capturing investor attention with its robust potential upside. As a prominent provider..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Unveiling a 148% Potential Upside Amidst Promising Pipeline

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands out in the biotech sector with a compelling investment thesis driven by its focus on rare and ultra-rare genetic diseases...

Organon & Co. (OGN) Stock Analysis: Tapping into a 51.35% Potential Upside Amidst Mixed Performance Indicators

For investors looking at the healthcare sector, Organon & Co. (NYSE: OGN) presents a fascinating case study. With a current market capitalization of $2.4 billion, this..

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: Exploring Growth Amidst 133.7% Revenue Increase

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) is rapidly gaining attention in the biotechnology sector, driven by an impressive 133.7% revenue growth in the past year. Based in..

ICU Medical, Inc. (ICUI) Stock Analysis: 42.64% Potential Upside Awaits Investors

ICU Medical, Inc. (NASDAQ: ICUI) stands as a formidable player in the healthcare sector, focusing on the development and manufacture of essential medical devices used globally..

NewAmsterdam Pharma (NAMS) Stock Analysis: 126% Potential Upside Captivates Investors

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a key player in the biotechnology sector, is garnering significant attention from investors due to its impressive potential upside of..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds